Fazadinium in anaesthesia.
The clinical use of the neuromuscular blocking agent fazadinium was investigated in a survey of 500 patients. Rapid conditions for tracheal intubation followed by excellent relaxation and easy antagonism were obtained. It is suggested that these findings commend it as an alternative to suxamethonium. Tachycardia appeared to be the only disadvantage associated with its use.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D005260:Female; D006801:Humans; D007442:Intubation, Intratracheal; D008297:Male; D008875:Middle Aged; D009407:Nerve Block / Q000379:methods*; D011726:Pyridinium Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000037:antagonists & inhibitors
D011726:Pyridinium Compounds